Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Alzheimer's Disease

  Free Subscription


22.01.2024

1 Alzheimer Dis Assoc Disord
21 Alzheimers Dement
1 Biochemistry
1 Br J Psychiatry
3 Brain
1 Curr Opin Neurol
1 Exp Gerontol
1 Int J Neurosci
6 J Alzheimers Dis
1 Nat Med
1 Neurobiol Aging
1 Neurobiol Dis
1 Neurochem Res
1 Neurol Clin Pract
1 Neurology
1 Neuroscience
1 PLoS Biol
3 PLoS One
1 Rev Neurol


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Alzheimer Dis Assoc Disord

  1. KOBAYASHI R, Morioka D, Kawakatsu S, Sakamoto K, et al
    Application of Suggestive Biomarkers in Dementia With Lewy Bodies With Masking of Typical Clinical Symptoms by Alzheimer Disease-type Pathology.
    Alzheimer Dis Assoc Disord. 2024 Jan 17. doi: 10.1097/WAD.0000000000000597.
    PubMed         Abstract available


    Alzheimers Dement

  2. SALONER R, VandeVrede L, Asken BM, Paolillo EW, et al
    Plasma phosphorylated tau-217 exhibits sex-specific prognostication of cognitive decline and brain atrophy in cognitively unimpaired adults.
    Alzheimers Dement. 2024;20:376-387.
    PubMed         Abstract available

  3. WANG X, Sundermann EE, Buckley RF, Banks SJ, et al
    Sex differences in the association between tau PET and cognitive performance in a non-Hispanic White cohort with preclinical AD.
    Alzheimers Dement. 2024;20:25-33.
    PubMed         Abstract available

  4. ZAMMIT MD, Betthauser TJ, McVea AK, Laymon CM, et al
    Characterizing the emergence of amyloid and tau burden in Down syndrome.
    Alzheimers Dement. 2024;20:388-398.
    PubMed         Abstract available

  5. LIU W, Yu L, Deng Q, Li Y, et al
    Toward digitally screening and profiling AD: A GAMLSS approach of MemTrax in China.
    Alzheimers Dement. 2024;20:399-409.
    PubMed         Abstract available

  6. MADSEN LS, Kjeldsen PL, Ismail R, Parbo P, et al
    Capillary dysfunction in healthy elderly APOE epsilon4 carriers with raised brain Abeta deposition.
    Alzheimers Dement. 2024;20:459-471.
    PubMed         Abstract available

  7. LOPES KP, Yu L, Shen X, Qiu Y, et al
    Associations of cortical SPP1 and ITGAX with cognition and common neuropathologies in older adults.
    Alzheimers Dement. 2024;20:525-537.
    PubMed         Abstract available

  8. JAIN L, Khrestian M, Formica S, Tuason ED, et al
    ATN cerebrospinal fluid biomarkers in dementia with Lewy bodies: Initial results from the United States Dementia with Lewy Bodies Consortium.
    Alzheimers Dement. 2024;20:549-562.
    PubMed         Abstract available

  9. SRIKRISHNA M, Ashton NJ, Moscoso A, Pereira JB, et al
    CT-based volumetric measures obtained through deep learning: Association with biomarkers of neurodegeneration.
    Alzheimers Dement. 2024;20:629-640.
    PubMed         Abstract available

  10. POMARA N, Imbimbo BP
    Do anti-Abeta monoclonal antibodies lower brain plaques in Alzheimer patients through microglia activation?
    Alzheimers Dement. 2024 Jan 15. doi: 10.1002/alz.13684.
    PubMed        

  11. TSOY E, La Joie R, VandeVrede L, Rojas JC, et al
    Scalable plasma and digital cognitive markers for diagnosis and prognosis of Alzheimer's disease and related dementias.
    Alzheimers Dement. 2024 Jan 15. doi: 10.1002/alz.13686.
    PubMed         Abstract available

  12. LANDAU SM, Lee J, Murphy A, Ward TJ, et al
    Individuals with Alzheimer's disease and low tau burden: Characteristics and implications.
    Alzheimers Dement. 2024 Jan 19. doi: 10.1002/alz.13609.
    PubMed         Abstract available

  13. WANG X, St George RJ, Bindoff AD, Noyce AJ, et al
    Estimating presymptomatic episodic memory impairment using simple hand movement tests: A cross-sectional study of a large sample of older adults.
    Alzheimers Dement. 2024;20:173-182.
    PubMed         Abstract available

  14. CAMINITI SP, De Francesco S, Tondo G, Galli A, et al
    FDG-PET markers of heterogeneity and different risk of progression in amnestic MCI.
    Alzheimers Dement. 2024;20:159-172.
    PubMed         Abstract available

  15. DENG J, Sun B, Kavcic V, Liu M, et al
    Novel methodology for detection and prediction of mild cognitive impairment using resting-state EEG.
    Alzheimers Dement. 2024;20:145-158.
    PubMed         Abstract available

  16. WALKIEWICZ G, Ronisz A, Van Ginderdeuren R, Lemmens S, et al
    Primary retinal tauopathy: A tauopathy with a distinct molecular pattern.
    Alzheimers Dement. 2024;20:330-340.
    PubMed         Abstract available

  17. HARDY CJD, Taylor-Rubin C, Taylor B, Harding E, et al
    Symptom-led staging for semantic and non-fluent/agrammatic variants of primary progressive aphasia.
    Alzheimers Dement. 2024;20:195-210.
    PubMed         Abstract available

  18. VAN DER HEIDE FCT, Khawaja A, Berendschot TTJM, Littlejohns TJ, et al
    Associations of inner retinal layers with risk of incident dementia: An individual participant data analysis of four prospective cohort studies.
    Alzheimers Dement. 2024;20:211-220.
    PubMed         Abstract available

  19. BOCCALINI C, Ribaldi F, Hristovska I, Arnone A, et al
    The impact of tau deposition and hypometabolism on cognitive impairment and longitudinal cognitive decline.
    Alzheimers Dement. 2024;20:221-233.
    PubMed         Abstract available

  20. TITCOMB TJ, Richey P, Casanova R, Phillips LS, et al
    Association of type 2 diabetes mellitus with dementia-related and non-dementia-related mortality among postmenopausal women: A secondary competing risks analysis of the women's health initiative.
    Alzheimers Dement. 2024;20:234-242.
    PubMed         Abstract available

  21. GAUTHREAUX K, Kukull WA, Nelson KB, Mock C, et al
    Different cohort, disparate results: Selection bias is a key factor in autopsy cohorts.
    Alzheimers Dement. 2024;20:266-277.
    PubMed         Abstract available

  22. PEZZOLI S, Giorgio J, Martersteck A, Dobyns L, et al
    Successful cognitive aging is associated with thicker anterior cingulate cortex and lower tau deposition compared to typical aging.
    Alzheimers Dement. 2024;20:341-355.
    PubMed         Abstract available


    Biochemistry

  23. RUTTENBERG SM, Kreutzer AG, Truex NL, Nowick JS, et al
    beta-Hairpin Alignment Alters Oligomer Formation in Abeta-Derived Peptides.
    Biochemistry. 2024;63:212-218.
    PubMed         Abstract available


    Br J Psychiatry

  24. LAURELL AAS, Venkataraman AV, Schmidt T, Montagnese M, et al
    Estimating demand for potential disease-modifying therapies for Alzheimer's disease in the UK.
    Br J Psychiatry. 2024 Jan 18:1-7. doi: 10.1192/bjp.2023.
    PubMed         Abstract available


    Brain

  25. HAN Y, Chen K, Zhang B, Yu H, et al
    Maf1 loss regulates spinogenesis and attenuates cognitive impairment in Alzheimer's disease.
    Brain. 2024 Jan 16:awae015. doi: 10.1093.
    PubMed         Abstract available

  26. KIIANITSA K, Lukes ME, Hayes BJ, Brutman J, et al
    TREM2 variants that cause early dementia and increase Alzheimer's disease risk affect gene splicing.
    Brain. 2024 Jan 16:awae014. doi: 10.1093.
    PubMed         Abstract available

  27. KUMAR M, Quittot N, Dujardin S, Schlaffner CN, et al
    Alzheimer proteopathic tau seeds are biochemically a forme fruste of mature paired helical filaments.
    Brain. 2024 Jan 18:awad378. doi: 10.1093.
    PubMed         Abstract available


    Curr Opin Neurol

  28. NICOLAS G
    Recent advances in Alzheimer disease genetics.
    Curr Opin Neurol. 2024 Jan 19. doi: 10.1097/WCO.0000000000001242.
    PubMed         Abstract available


    Exp Gerontol

  29. DA SILVA RODRIGUES G, Noronha NY, Noma IHY, de Lima JGR, et al
    14-Week exercise training modifies the DNA methylation levels at gene sites in non-Alzheimer's disease women aged 50 to 70 years.
    Exp Gerontol. 2024 Jan 15:112362. doi: 10.1016/j.exger.2024.112362.
    PubMed         Abstract available


    Int J Neurosci

  30. FOTUHI SN, Khalaj-Kondori M
    Imbalanced clearance of Abeta peptide cause presynaptic plaque formation.
    Int J Neurosci. 2024;134:66-70.
    PubMed         Abstract available


    J Alzheimers Dis

  31. VALENTIN-ESCALERA J, Leclerc M, Calon F
    High-Fat Diets in Animal Models of Alzheimer's Disease: How Can Eating Too Much Fat Increase Alzheimer's Disease Risk?
    J Alzheimers Dis. 2024 Jan 4. doi: 10.3233/JAD-230118.
    PubMed         Abstract available

  32. SAFIEH M, Liraz O, Ovadia M, Michaelson D, et al
    The Role of Impaired Receptor Trafficking in Mediating the Pathological Effects of APOE4 in Alzheimer's Disease.
    J Alzheimers Dis. 2024 Jan 5. doi: 10.3233/JAD-230514.
    PubMed         Abstract available

  33. WU LY, Chong JR, Chong JPC, Hilal S, et al
    Serum Placental Growth Factor as a Marker of Cerebrovascular Disease Burden in Alzheimer's Disease.
    J Alzheimers Dis. 2024 Jan 8. doi: 10.3233/JAD-230811.
    PubMed         Abstract available

  34. HAN Y, Huang C, Pan Y, Gu X, et al
    Single Cell Sequencing Technology and Its Application in Alzheimer's Disease.
    J Alzheimers Dis. 2024 Jan 8. doi: 10.3233/JAD-230861.
    PubMed         Abstract available

  35. CHEN M, Wang F, Lei H, Yang Z, et al
    In Silico Insights into Micro-Mechanism Understanding of Extracts of Taxus Chinensis Fruits Against Alzheimer's Disease.
    J Alzheimers Dis. 2024 Jan 12. doi: 10.3233/JAD-231066.
    PubMed         Abstract available

  36. STONE J, Mitrofanis J, Johnstone DM, Robinson SR, et al
    The Catastrophe of Intracerebral Hemorrhage Drives the Capillary-Hemorrhage Dementias, Including Alzheimer's Disease.
    J Alzheimers Dis. 2024 Jan 5. doi: 10.3233/JAD-231202.
    PubMed         Abstract available


    Nat Med

  37. O'LEARY K
    Modeling real-world data to repurpose drugs for Alzheimer's disease.
    Nat Med. 2024 Jan 18. doi: 10.1038/d41591-024-00003.
    PubMed        


    Neurobiol Aging

  38. LAN F, Roquet D, Dalton MA, El-Omar H, et al
    Exploring graded profiles of hippocampal atrophy along the anterior-posterior axis in semantic dementia and Alzheimer's disease.
    Neurobiol Aging. 2024;135:70-78.
    PubMed         Abstract available


    Neurobiol Dis

  39. IVANOVA M, Belaya I, Kucharikova N, de Sousa Maciel I, et al
    Upregulation of Integrin beta-3 in astrocytes upon Alzheimer's disease progression in the 5xFAD mouse model.
    Neurobiol Dis. 2024;191:106410.
    PubMed         Abstract available


    Neurochem Res

  40. ALLNUTT MA, Matera KM
    Stabilization and Reduced Cytotoxicity of Amyloid Beta Aggregates in the Presence of Catechol Neurotransmitters.
    Neurochem Res. 2024;49:379-387.
    PubMed         Abstract available


    Neurol Clin Pract

  41. RITCHIE M, Sajjadi SA, Grill JD
    Apolipoprotein E Genetic Testing in a New Age of Alzheimer Disease Clinical Practice.
    Neurol Clin Pract. 2024;14:e200230.
    PubMed         Abstract available


    Neurology

  42. PARK SY, Setiawan VW, Crimmins EM, White LR, et al
    Racial and Ethnic Differences in the Population-Attributable Fractions of Alzheimer Disease and Related Dementias.
    Neurology. 2024;102:e208116.
    PubMed         Abstract available


    Neuroscience

  43. QIAO Y, Liu H, He C, Ma Y, et al
    ApoE Mimic Peptide COG1410 Reduces Abeta Deposition and Improves Cognitive Function by Inducing the Transformation of A1/A2 Reactive Astrocytes and Increasing the BDNF Concentration in Brain of APP/PS1 Double Transgenic Mice.
    Neuroscience. 2024;537:116-125.
    PubMed         Abstract available


    PLoS Biol

  44. ZHANG X, Zou L, Tang L, Xiong M, et al
    Bridging integrator 1 fragment accelerates tau aggregation and propagation by enhancing clathrin-mediated endocytosis in mice.
    PLoS Biol. 2024;22:e3002470.
    PubMed         Abstract available


    PLoS One

  45. GAMMIE SC, Messing A, Hill MA, Kelm-Nelson CA, et al
    Large-scale gene expression changes in APP/PSEN1 and GFAP mutation models exhibit high congruence with Alzheimer's disease.
    PLoS One. 2024;19:e0291995.
    PubMed         Abstract available

  46. KONG F, Wu T, Dai J, Cai J, et al
    Knowledge domains and emerging trends of Genome-wide association studies in Alzheimer's disease: A bibliometric analysis and visualization study from 2002 to 2022.
    PLoS One. 2024;19:e0295008.
    PubMed         Abstract available

  47. PARKS ME
    Stochastic model of Alzheimer's disease progression using two-state Markov chains.
    PLoS One. 2024;19:e0295578.
    PubMed         Abstract available


    Rev Neurol

  48. MORALES-CASADO MI, Diezma-Martin AM, Munoz-Escudero F, Ronsenstone-Calvo S, et al
    Association between myasthenia gravis and Alzheimer's disease.
    Rev Neurol. 2024;78:41-46.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.